Stay Updated
Press Releases
JANUARY 2022 PRICE HIKES REPORT: A New Year Brings The Same Old Bad Behavior By Big Pharma
Patients For Affordable Drugs’ Report Underscores Urgent Need For Drug Pricing Reform WASHINGTON, D.C. — As the pharmaceutical industry ushers in the new year with widespread price hikes on hundreds of life-saving and life-sustaining medications, Patients For Affordable Drugs released a new report today that takes a closer look at the 554 price hikes so far this month, […]
Press Releases
STATEMENT: Drug Companies Continue To Raise Prices At Will; Congress Must Act
WASHINGTON, D.C. — In response to reports that Big Pharma kicked off the year with increased prices on 442 drugs and more price hikes expected, David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, issued the following statement: “At a time when Americans are struggling with the surging omicron variant and prices […]
Press Releases
WASHINGTON, D.C. — Cancer patient and founder of Patients For Affordable Drugs David Mitchell joined House Oversight and Reform Committee Chairwoman Carolyn Maloney, Speaker Nancy Pelosi, congressional leaders, and advocates at a press conference today that revealed the final findings from the committee’s nearly three-year investigation into pharmaceutical pricing and business practices. The committee’s findings sharply […]
Press Releases
ICYMI: New Video Tells The Truth About COVID-19 Vaccines
WASHINGTON, D.C. — As Big Pharma is working overtime to sell the story that drug corporations saved us from COVID-19 by developing new vaccines, Patients For Affordable Drugs released a new video and fact sheet this week explaining the mRNA vaccines’ true origin story. The truth is the federal government invested billions of dollars to make […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs released an extensive fact check today that takes on Big Pharma’s lies in recent ads, which total more than $18 million this year, attacking drug pricing reforms that include allowing Medicare to negotiate lower drug prices. The fact check breaks down six false claims in pharma-funded ads, including misleading […]
Reports
Press Releases
WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, in response to the Food and Drug Administration’s approval of Mylan’s Semglee as an interchangeable biosimilar to Sanofi’s long-acting Lantus (glargine) insulin: “The FDA’s approval of Semglee as an interchangeable biosimilar to Lantus is an […]